Japan has a huge and well established pharmaceutical market with high quality drug standards.
The Japanese pharmaceutical market, which is second only to the US, represents one of the strongest areas for those looking to invest. It has been forecast to grow at a CAGR of 2.6 per cent until 2016, reaching a total value of US$127.4 billion.
Japan is one of the world's most technologically advanced countries. Japan's APIs, intermediates producers and pharmaceutical manufacturers are always on the lookout for new technologies in quality control, safety assurance, and increasing production efficiency. The requirements of Japanese companies are possibly the highest in the world. For suppliers of competitive products in these three fields, Japan offers tremendous opportunities.
Changes in the market environment, together with an ageing population have resulted in a great drug demand, especially in the generic and biotechnology sectors. Changing demographics in Japan have prompted its government to create legislation that supports foreign investment in the pharmaceutical industry. The government wants generics to account for a 30 per cent market share and pharma companies are actively looking for international partners to help them boost capacity.
The generics sector is expected to increase their market share of sales from just over eight per cent in 2010 to almost 13 per cent in 2015. As the use of generic drugs in Japan continues to expand, Japanese pharmaceutical manufacturers and traders are urgently seeking to secure new and reliable suppliers of price-competitive and high-quality pharmaceutical ingredients. This trend is providing lucrative new business opportunities to international API suppliers.
The pharma community in Japan continues to innovate, particularly in regards to medical devices. More recently, Japan has seen more amicable regulatory guidelines, which has generated an attractive platform for international investment. Especialy 2014 will be marked as a transition year for the Japanese Pharma industry, according to industry observers.
In order to tap the potential of this rising sector, the land of Rising Sun is once again hosting the mega pharma event, CPhI Japan 2014. The event which is returning for its twelfth year to Tokyo will be held at Big Sight Exhibition Centre from the April 9 to 11.The event will once again be co-locating to provide an all-round experience, creating a pivotal meeting-point for all sectors of the pharma industry brining together over 14,000 pharma professionals.
The full line-up of events includes ICSE Japan, a dedicated outsourcing event designed to connect the pharmaceutical community with contract service providers; P-MEC Japan, delivering innovative pharmaceutical technology, machinery and equipment to a forum of decision makers; BioPh Japan, showcasing the biopharma sector, and a further two events- Pharmatec, providing a pharmaceutical packaging focus and MEDTEC Japan, specialising in medical devices.
Says Chris Kilbee, Group Director,Pharma, UBM Live, organizer of the event"As the Japanese pharmaceutical market continues to expand and become ever more international, CPhI Japan plays a very important role in facilitating new business opportunities for both domestic and international companies. Now in its thirteenth year, the event has become the largest gathering for the pharmaceutical industry in Japan and also attracts large numbers of buyers from neighbouring countries such as Korea and China. Running alongside the CPhI Japan exhibition is an extensive program of conferences, seminars and workshops. This means that the event attracts the whole spectrum of professionals in the pharmaceutical industry, from R&D and production specialists to purchasing managers and top management".
"Further adding to the gravity of the event is the fact that Japan’s leading exhibition for the medical devices industry, MEDTEC Japan, is held concurrently with CPhI Japan. With the ever-increasing integration of pharmaceuticals and medical device technology, the colocation of the events yields even greater business opportunities" , he adds.
The event is the ultimate one-stop-shop for all pharma relevant activity concerning Japan. It enables to meet key decision makers who are looking for new products and services, business opportunities and partnerships. It brings face-to-face with old, new and potential customers, benefit from new pharmaceutical laws that make business opportunities for international companies easier and showcases latest products and innovations in a cost-effective way
Exhibitor can reap the rewards of new business partnerships, new distribution routes and one-to-one relationships with senior pharmaceutical manufacturing professionals by participating at CPhI Japan 2014.
A major highlight for this year’s event is the 150 free seminars covering current industry trends and providing invaluable insights into the dynamic Japanese pharmaceutical industry. Contributors to the seminars include a wide spectrum of esteemed representatives including the Ministry of Health, Labour & Welfare Japan and the European Federation of Pharmaceutical Industries & Associations Japan (EFPIA Japan).
P-MEC Japan
P-MEC Japan gives the opportunity to showcase innovative pharmaceutical machinery, laboratory equipment and analytical technology for API and Intermediates through face to face networking and education.
Japan's medical device market is projected to expand at a Compounded Annual Growth Rate of 2.5 per cent in between 2013 and 2018. The market is estimated to grow to around US$33.6 billion in 2018.
Following its successful launch in 2008, P-MEC Japan, the pharmaceutical machinery and equipment convention, will provide an excellent opportunity to present advanced technologies to the most sophisticated market in Asia.
ICSE Japan
Held alongside CPhI Japan, ICSE attracts international exhibitors who are keen to capitalise on the benefits of doing business in Japan. Besides contract manufacturing and contract research, other main services provided are packaging, clinical trials, laboratory services, drug discovery and marketing services.
ICSE Japan connects the pharmaceutical community with diverse outsourcing solutions such as: clinical trials, contract manufacturing, contract research, packaging, logistics or analytical services. It will enable attendees to find a broad range of products with the latest developments and meet the company representatives in person.
BioPh Japan
BioPh Japan brings bio solutions to CPhI Japan and is meant for companies and organisations involved in the research and development of new treatment methods arising from biotechnical processes or which are derived from, or use live organisms. For a supplier of bio pharma raw materials, services or equipment, this gives an opportunity to enjoy enhanced visibility by exhibiting in this hot-topic pavilion
Structural economic reforms in Japan have fuelled a continued rally in biotechnology. The Japanese pharmaceutical manufacturers have been eager to catch up the US and European players in the bio
field by investing and co-operating with bio ventures & universities.
The government has also been investing in infrastructure development such as bio industrial cluster projects and setting up support programs for bio ventures and universities in order to enhance Japan's bio pharma industry.
Pharmatec Japan
Pharmatec Japan is a Quality Event for "Drug Packaging and Delivery Technology" for the pharmaceutical, biopharmaceutical, veterinary and medical industries, generate a synergistic effect on drawing pharma professional's attention in Japan being held in parallel with other international pharma events, CPhI, ICSE, P-MEC and BioPh. Pharmatec Japan 2014 will be rechristened as InnoPack Japan in 2015.
MEDTEC Japan
MEDTEC Japan is the single annual opportunity to meet the key design and manufacturing engineers working for medical device manufacturers in Japan in one place at one time. Its focus is on allowing suppliers able to provide technology suitable for use in the manufacture of medical devices to meet with key design and manufacturing personnel from Japan based medical OEM's.
MEDTEC Japan is expected to become the "largest show" specifically for the medical device manufacturing & design technology.
Seminars and conferences
With a wide range of companies from all areas of pharma active in Japan as well as free to attend seminars presented by governmental bodies and other important institutions, CPhI Japan is a way to successfully enter this highly profitable market.
The event covers the trending industry topics giving valuable insight to the Japanese pharma industry. As the industry undergoes changes, attending the seminars and conferences at CPhI Japan will give a competitive advantage that helps to access the world's second largest pharma market.
Topics to be discussed at the conference are 'Next step for development of next-generation biopharmaceutical manufacturing, 'On the Cutting Edge of Drug Discovery tools utilizing ES & iPSCs, Essentials Required for Pharmaceutical Manufacturing Business.' There are several type of seminars covering various topics under it like, ' theme seminars, biopharma seminars, pharmatec Japan conference, the latest trend of pharmaceutical industry in India, exhibitor seminar.'
Last year, CPhI Japan had attracted over 14,000 attendees and more than 500 exhibitors."This year we strive to be even better and it is expected that the event will host even more industry representatives from across the globe. Our co-located events also contributed to the event’s success. The seminar series throughout the event was very well received and, as such, will be back again this year highlighting current industry trends and offering attendees further insights into the Japanese market", says Chris Kilbee.